SUPERNUS PHARMACEUTICALS INC. - COMMON STOCK
32,84
02-мая-25 15:45:00
15 мин. задержка
Акции
+0,39
+1,20%
Сегодняшний диапазон
32,43 - 33,28
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
17 окт 2024 15:05:25 Источник Nasdaq GlobeNewswire
-
10 окт 2024 16:12:14 Источник Nasdaq GlobeNewswire
-
24 сен 2024 06:30:33 Источник Nasdaq GlobeNewswire
-
19 сен 2024 15:30:44 Источник Nasdaq GlobeNewswire
-
Supernus Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference
28 авг 2024 15:15:26 Источник Nasdaq GlobeNewswire
-
Supernus Announces SPN-830 Apomorphine Infusion Device NDA Accepted for Review by FDA
19 авг 2024 06:00:51 Источник Nasdaq GlobeNewswire
-
Supernus Announces Second Quarter 2024 Financial Results
06 авг 2024 15:06:00 Источник Nasdaq GlobeNewswire
-
Supernus Resubmits NDA for SPN-830 Apomorphine Infusion Device
01 авг 2024 15:30:11 Источник Nasdaq GlobeNewswire
-
23 июл 2024 15:13:37 Источник Nasdaq GlobeNewswire
-
Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
30 май 2024 15:25:33 Источник Nasdaq GlobeNewswire
-
23 май 2024 15:05:48 Источник Nasdaq GlobeNewswire
-
09 май 2024 15:05:39 Источник Nasdaq GlobeNewswire
-
Supernus Announces First Quarter 2024 Financial Results
08 май 2024 15:05:50 Источник Nasdaq GlobeNewswire
-
Busy Philipps Shines Spotlight on ADHD in Women and Shares her Qelbree Story
01 май 2024 07:00:32 Источник Nasdaq GlobeNewswire
-
24 апр 2024 15:05:53 Источник Nasdaq GlobeNewswire
-
Supernus Provides Regulatory Update for SPN-830
08 апр 2024 07:00:16 Источник Nasdaq GlobeNewswire
-
Supernus to Participate in Two Upcoming Investor Conferences
06 мар 2024 15:30:50 Источник Nasdaq GlobeNewswire
-
Supernus to Participate in the TD Cowen 44th Annual Healthcare Conference
28 фев 2024 15:30:04 Источник Nasdaq GlobeNewswire
-
Supernus Announces Fourth Quarter and Full Year 2023 Financial Results
27 фев 2024 15:05:33 Источник Nasdaq GlobeNewswire
-
13 фев 2024 15:05:20 Источник Nasdaq GlobeNewswire